-
公开(公告)号:US11458125B2
公开(公告)日:2022-10-04
申请号:US16090993
申请日:2017-04-03
发明人: Nigel Crutchley
摘要: The present invention relates to a composition for topical application comprising: a first discontinuous phase comprising a first oil and tacrolimus; a second discontinuous phase comprising a second oil; and a continuous aqueous phase; wherein the first oil is different from the second oil.
-
公开(公告)号:US11638711B2
公开(公告)日:2023-05-02
申请号:US16982281
申请日:2019-03-18
IPC分类号: A61K31/4709 , A61K9/06 , A61K47/10 , A61K47/12 , A61P17/10 , A61P17/00 , A61P17/04 , A61P31/04 , A61K31/573 , A61K9/00 , A61K31/047 , A61K31/085 , A61K31/355 , A61K47/44
摘要: The present invention relates to a composition for topical application comprising a polyaphron dispersion, the polyaphron dispersion comprising a continuous aqueous phase and at least one discontinuous oil phase, wherein the polyaphron dispersion comprises calcipotriol, betamethasone dipropionate, alpha-tocopherol and butylated hydroxyanisole, and wherein the composition has a pH of 7.75±0.5.
-
公开(公告)号:US20210015831A1
公开(公告)日:2021-01-21
申请号:US16982281
申请日:2019-03-18
IPC分类号: A61K31/573 , A61K31/355 , A61K31/047 , A61K31/085 , A61K9/00 , A61K47/44
摘要: The present invention relates to a composition for topical application comprising a polyaphron dispersion, the polyaphron dispersion comprising a continuous aqueous phase and at least one discontinuous oil phase, wherein the polyaphron dispersion comprises calcipotriol, betamethasone dipropionate, alpha-tocopherol and butylated hydroxyanisole, and wherein the composition has a pH of 7.75±0.5.
-
-